Morphology and histogenesis of human fetal thyroid gland von Y Jalaja, C P Anbarasi

Volltext

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments von Agarwal, Suresh K., PhD, DiNardo, Courtney D., MD, Potluri, Jalaja, MD, Dunbar, Martin, DrPH, Kantarjian, Hagop M., MD, Humerickhouse, Rod A., MD, PhD, Wong, Shekman L., PhD, Menon, Rajeev M., PhD, Konopleva, Marina Y., MD, PhD, Salem, Ahmed Hamed, PhD

Volltext

Adsorption behaviour on silver nanocolloids at various concentrations of a bioactive therapeutic derivative of methylhydrazine: Experimental, DFT and molecular docking investigatio... von Al-Otaibi, Jamelah S., Sheena Mary, Y., Shyma Mary, Y., Krátký, Martin, Vinsova, Jarmila, Jalaja, K., Cristina Gamberini, Maria

Volltext

Essential oils from plant resources as potent insecticides and repellents: Current status and future perspectives von Jyotsna, B., Patil, Swaroopa, Prakash, Y. Surya, Rathnagiri, P., Kavi Kishor, P.B., Jalaja, N.

Volltext

Spectroscopic characterization of 1-[3-(1H-imidazol-1-yl)propyl]-3-phenylthiourea and assessment of reactive and optoelectronic properties employing DFT calculations and molecular... von War, Javeed Ahmad, Jalaja, K., Mary, Y. Sheena, Panicker, C. Yohannan, Armaković, Stevan, Armaković, Sanja J., Srivastava, Santosh Kumar, Van Alsenoy, C.

Volltext

Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib von Byrd, John C., Wierda, William G., Davids, Matthew Steven, Choi, Michael Y., Furman, Richard R., Mato, Anthony R., Zhou, Lang, Verdugo, Maria E., Potluri, Jalaja, Coutre, Steven

Volltext

Spectroscopic characterization of 4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzaldehyde oxime and investigation of its reactive properties by DFT calculations and molecular dynamics simula... von Jalaja, K., Mary, Y. Sheena, Panicker, C. Yohannan, Armaković, Stevan, Armaković, Sanja J., Sagar, B.K., Girisha, M., Yathirajan, H.S., Van Alsenoy, C.

Volltext

Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy von Pollyea, Daniel A, Pratz, Keith W., Jonas, Brian A., Letai, Anthony, Pullarkat, Vinod A., Wei, Andrew, Konopleva, Marina Y., Recher, Christian, Frankfurt, Olga, Rizzieri, David, Xu, Tu, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, DiNardo, Courtney D.

Volltext

Vibrational spectroscopic investigations and molecular docking studies of biologically active 2-[4-(4-phenylbutanamido)phenyl]-5-ethylsulphonyl-benzoxazole von Jalaja, K., Al-Alshaikh, Monirah A., Mary, Y. Sheena, Panicker, C. Yohannan, El-Emam, Ali A., Temiz-Arpaci, Ozlem, Alsenoy, C. Van

Volltext

Pooled Multi-Trial Analysis of Venetoclax Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia von Roberts, Andrew W., Seymour, John F, Eichhorst, Barbara, Stilgenbauer, Stephan, Choi, Michael Y., Davids, Matthew S., Gerecitano, John F., Popovic, Relja, Chyla, Brenda, Zhu, Ming, Verdugo, Maria, Potluri, Jalaja, Lash, Leanne, Kim, Su Young, Hallek, Michael

Volltext

Spectroscopic analysis (FT-IR, FT-Raman and NMR) and molecular docking study of ethyl 2-(4-oxo-3-phenethyl-3,4-dihydroquinazolin-2-ylthio)-acetate von El-Azab, Adel S., Jalaja, K., Abdel-Aziz, Alaa A.-M., Al-Obaid, Abdulrahman M., Sheena Mary, Y., Yohannan Panicker, C., Van Alsenoy, C.

Volltext

Synthesis, vibrational spectroscopic investigations, molecular docking, antibacterial studies and molecular dynamics study of 5-[(4-nitrophenyl)acetamido]-2-(4-tert-butylphenyl)ben... von Sheena Mary, Y., Al-Shehri, Mona M., Jalaja, K., Al-Omary, Fatmah A.M., El-Emam, Ali A., Yohannan Panicker, C., Armaković, Stevan, Armaković, Sanja J., Temiz-Arpaci, Ozlem, Van Alsenoy, C.

Volltext

Preliminary Results of a Phase 2, Open-Label Study of Venetoclax (ABT-199/GDC-0199) Monotherapy in Patients with Chronic Lymphocytic Leukemia Relapsed after or Refractory to Ibruti... von Jones, Jeffrey, Mato, Anthony R., Coutre, Steven, Wierda, William, Choi, Michael Y., Davids, Matthew S., Lamanna, Nicole, Barr, Paul, Burns, Kim, Montalvo, Nicholas, Zhu, Ming, Busman, Todd, Potluri, Jalaja, Humerickhouse, Rod A., Byrd, John C.

Volltext

Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib von Jones, Jeffrey, Choi, Michael Y., Mato, Anthony R., Furman, Richard R., Davids, Matthew S., Heffner, Leonard T., Cheson, Bruce D., Lamanna, Nicole, Barr, Paul M., Eradat, Herbert, Halwani, Ahmad, Chyla, Brenda, Zhu, Ming, Verdugo, Maria, Humerickhouse, Rod A., Potluri, Jalaja, Wierda, William G., Coutre, Steven E.

Volltext

Venetoclax activity in CLL patients who have relapsed after or are refractory to ibrutinib or idelalisib von Jones, Jeffrey Alan, Wierda, William G., Choi, Michael Y., Davids, Matthew Steven, Cheson, Bruce D., Furman, Richard R., Lamanna, Nicole, Barr, Paul M., Eradat, Herbert Aaron, Halwani, Ahmad Sami, Heffner, Leonard T., Chyla, Brenda, Zhu, Ming, Potluri, Jalaja, Verdugo, Maria E., Humerickhouse, Rod, Mato, Anthony R., Coutre, Steven

Volltext